Cryoablation Devices market set for 10.26% CAGR growth from 2024-2032, fueled by rising cancer and cardiovascular disease prevalence. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 email us here Visit ...

IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

I don’t believe the PRESERVE prostate cancer study has been published yet ... (or HIFU), focal laser ablation (or FLA), and cryoablation appear to offer moderately less efficacy with similar ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being ...

The urine test, called MyProstateScore 2.0, or MPS2, looks at 18 different genes linked to high-grade prostate cancer. The researchers had previously demonstrated that the test was effective in ...

Hospital length of stay, hospital costs, and opioid use were reduced among patients who underwent cryoablation during ...

OncoAssure Ltd, an Irish medical diagnostic company, announced the publication of new data in the journal BJUI Compass that ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

The FDA granted fast track designation to 64Cu-SAR-bisPSMA for PET imaging of PSMA-positive prostate cancer lesions in ...

Announcing a new publication for Acta Materia Medica journal. Prostate cancer (PrCa) is the most prevalent urogenital cancer affecting men.

Prostate cancer is now the most common cancer in the UK, according to new analysis - as a leading charity renewed its calls for a national screening program. NHS data found 55,033 men were ...